Finance

Lists
Why is CLYM up 16,01%?
Dive Deeper
CLYM:NASDAQ
Climb Bio Inc
10,29 $
+16,01%
(+1,42) 1D
10,34 $
+0,49% (+0,050)
After hours
Closed: 6 նոյ, 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLYM...
Open
9,05 $
High
10,33 $
Low
8,84 $
Mkt. cap
591,02 մլն
Avg. vol.
1,17 մլն
Volume
1,14 մլն
52-wk high
18,33 $
52-wk low
1,64 $
EPS
-0,82 $
Beta
0,04
Shares outstanding
57,44 մլն
No. of employees
29
Open
9,05 $
High
10,33 $
Low
8,84 $
Mkt. cap
591,02 մլն
Avg. vol.
1,17 մլն
Volume
1,14 մլն
52-wk high
18,33 $
52-wk low
1,64 $
EPS
-0,82 $
Beta
0,04
Shares outstanding
57,44 մլն
No. of employees
29
News stories
From web sources and news partners
About Climb Bio Inc
CEO-
Employees29
Founded2018
HeadquartersWellesley Hills, Մասսաչուսեթս, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Analyst ratings
Based on 12 analysts giving stock ratings to CLYM in the past 3 months
Strong buy
Buy
12
Hold
0
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for CLYM in the last 3 months.
Highest
Current 10,29 $
40,00 $ (+288,73%)
Average
29,09 $ (+182,70%)
Lowest
23,00 $ (+123,52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Danielle Brill
Truist Financial
Buy
Maintained
25,00 $
+143%
11/06/2026
Laura Chico
Wedbush
Buy
Maintained
27,00 $
+162,4%
11/06/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
25,00 $
+143%
11/06/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
35,00 $
+240,1%
11/05/2026
Julian Harrison
BTIG
Buy
Maintained
32,00 $
+211%
11/04/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
40,00 $
+288,7%
10/30/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
30,00 $
+191,5%
10/27/2026
David Hoang
Deutsche Bank
Buy
Initiated
28,00 $
+172,1%
10/20/2026
Nevin Varghese
RBC Capital
Buy
Maintained
23,00 $
+123,5%
10/13/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
30,00 $
+191,5%
09/04/2026
Brian Skorney
Robert W. Baird
Buy
Maintained
25,00 $
+143%
09/03/2026
Matt Phipps
William Blair
Buy
Maintained
-
-
09/03/2026
Leland Gershell
Oppenheimer
Buy
Maintained
18,00 $
+74,9%
08/07/2026
Christopher Raymond
Raymond James
Buy
Maintained
-
-
06/24/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
-
-
06/12/2026
Colleen M. Kusy
Robert W. Baird
Buy
Maintained
21,00 $
+104,1%
05/06/2026
Geulah Livshits
Chardan Capital
Buy
Initiated
22,00 $
+113,8%
05/05/2026
Joseph Catanzaro
Mizuho Securities
Buy
Initiated
18,00 $
+74,9%
04/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
13,74 մլն
9,37 մլն
9,71 մլն
11,04 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,56 մլն
5,84 մլն
5,64 մլն
5,85 մլն
Operating expense
19,30 մլն
15,21 մլն
15,36 մլն
16,89 մլն
Total operating expenses
19,30 մլն
15,21 մլն
15,36 մլն
16,89 մլն
Operating income
-19,30 մլն
-15,21 մլն
-15,36 մլն
-16,89 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-17,52 մլն
-13,72 մլն
-13,50 մլն
-14,57 մլն
EBT excluding unusual items
-17,52 մլն
-13,72 մլն
-13,50 մլն
-14,57 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17,52 մլն
-13,72 մլն
-13,50 մլն
-14,57 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,26
-0,20
-0,18
-0,18
Interest and investment income
1,83 մլն
1,51 մլն
1,86 մլն
2,32 մլն
Interest expense
-
-
-
-
Net interest expenses
1,83 մլն
1,51 մլն
1,86 մլն
2,32 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-19,27 մլն
-15,17 մլն
-15,33 մլն
-16,70 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps